ArticleNeurotoxicity research2025
Hyperhomocysteinemia Induced Mitochondrial Dysfunction Disrupting the Eye Development.
Article in Neurotoxicity research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mitochondrial dynamics, including fusion and fission, are essential for neural cell function and survival during central nervous system development. These processes are vital for eye formation, which requires high energy to support cellular events, such as proliferation, differentiation, and apoptosis. However, different conditions can disrupt the normal development of the eye, such as hyperhomocysteinemia (HHcy), a metabolic disorder characterized by elevated homocysteine (Hcy) levels. This study aimed to evaluate the effects of HHcy on eye development of Gallus domesticus. Fertilized eggs were treated with 20 µmol Hcy at embryonic day 2 (E2), with analyses conducted at E6 and E10 using a combination of survival analysis, transmission electron microscopy, flow cytometry for mitochondrial proteins and autophagy markers, and cell viability assay, providing a comprehensive evaluation of HHcy toxicity. A significant 40% reduction in the survival rate relative to control was observed in HHcy-treated embryos. Although eye diameter remained unchanged, ultrastructural analyses revealed mitochondrial damage, including membrane rupture, loss, and disorganization of the cristae, induced by the exposure at both embryonic ages. Analysis of proteins involved in mitochondrial dynamics showed increased Drp1 (fission) and decreased Mfn1 and Mfn2 (fusion) in HHcy-treated embryos. At E10, these changes were accompanied by an increased number of mitochondrial profiles and reduced mitochondrial area. HHcy also induced a reduction in cell viability, highlighting its cytotoxic effects, particularly on mitochondria. Additionally, increased cytoplasmic vesicles and autophagy were observed in HHcy-treated embryos. These findings indicate that mitochondria are key targets of HHcy, with mitochondrial dynamics and ultrastructural integrity significantly impaired by the exposure. These changes highlight the harmful effects of high Hcy levels on embryonic development and eye formation, providing insights into its pathogenic effects.
Indexed as
Identifiers
41111098What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.